The dawn of the FemTech revolution

Break new ground ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ .

Share this email Share this email on LinkedIn   Share this email on Twitter   Share this email on Facebook   AN ARTICLE A DAY, PICKED BY OUR EDITORS FemTech is on the rise. In the course of just a few years, FemTech has grown to encompass a range of technology-enabled, consumer-centric products and solutions for women’s health needs. While it’s still early days, our research indicates that the dynamics underlying FemTech are accelerating: public awareness, company formation, and funding are surging. And because FemTech helps to increase female representation among researchers, inventors, investors, and founders, it can create more consumer-centric products and solutions that recognize and target women’s specific healthcare needs. A new article gives you the lay of the land, unpacking findings from research into 750-plus FemTech companies. — Molly Liebergall, digital editor, New York The dawn of the FemTech revolution As opportunities in women's health accelerate, FemTech is helping to match capital and talent to unmet needs—with promising early results. Break new ground   Quote of the Day “What gives me hope is that between human ingenuity and the science and technology that we have access to, we can right some of our wrongs, and we can create better futures. But we can’t approach that with outright fear or a complete utopian ideal. We have to take a pragmatic approach, and if we can do that, then yes, I think we live longer, better, healthier, happier lives, I really do.” —Amy Webb, CEO of the Future Today Institute, on how synthetic biology will be as common as artificial intelligence in a recent interview from McKinsey's Author Talks series Chart of the Day See today's chart   Also New Five agility myths in energy and heavy industries Agile working practices in energy and heavy industries can make them faster, more efficient, and more resilient. Here are five myths and their realities. Discover the truth   Building a better planet with satellite data Spire CEO Peter Platzer says the answers to some of Earth's biggest problems can be found in space. Reach for the stars   Unleashing the next wave of productivity in corporate business functions A how-to guide for maximizing the ROI of enterprise platform transformations in the consumer packaged goods industry Learn how to optimize   Follow our thinking Share these insights Did you enjoy this newsletter? Forward it to colleagues and friends so they can subscribe too. Was this issue forwarded to you? Sign up for it and sample our 40+ other free email subscriptions here. This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy. You received this email because you subscribed to the Daily Read newsletter. Manage subscriptions | Unsubscribe Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007